We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
26
Home Depot
HD
$332B
$117M 0.75%
305,977
+9,323
+3% +$3.41M
LRCX icon
27
Lam Research
LRCX
$382B
$115M 0.73%
1,180,330
+351,220
+42% +$30.9M
EMR icon
28
Emerson Electric
EMR
$82.9B
$111M 0.71%
977,577
+13,968
+1% +$1.43M
CDNS icon
29
Cadence Design Systems
CDNS
$90B
$109M 0.7%
350,198
+9,016
+3% +$2.67M
TSM icon
30
TSMC
TSM
$2.09T
$107M 0.69%
789,770
+207,357
+36% +$25.8M
HOLX
31
DELISTED
Hologic
HOLX
$107M 0.68%
1,371,917
+37,878
+3% +$2.82M
ISRG icon
32
Intuitive Surgical
ISRG
$121B
$103M 0.66%
257,067
-51,337
-17% -$19.4M
JPM icon
33
JPMorgan Chase
JPM
$939B
$97.4M 0.62%
486,210
-4,653
-0.9% -$840K
ECL icon
34
Ecolab
ECL
$75.6B
$84M 0.54%
363,688
+60,285
+20% +$12.8M
INCY icon
35
Incyte
INCY
$23.5B
$84M 0.54%
1,473,797
+433,508
+42% +$26M
PANW icon
36
Palo Alto Networks
PANW
$264B
$83M 0.53%
584,042
-212,796
-27% -$33.6M
MELI icon
37
Mercado Libre
MELI
$91.3B
$80.2M 0.51%
53,030
+1,609
+3% +$2.63M
AXP icon
38
American Express
AXP
$223B
$78.2M 0.5%
343,617
-26,664
-7% -$5.53M
PTC icon
39
PTC
PTC
$13.7B
$78.1M 0.5%
413,593
-120,920
-23% -$21.8M
WCN
40
Waste Connections
WCN
$42.8B
$77M 0.49%
447,641
-109,792
-20% -$17.6M
CSCO icon
41
Cisco
CSCO
$450B
$76.4M 0.49%
1,530,307
-664,305
-30% -$33.1M
TSLA icon
42
Tesla
TSLA
$1.24T
$76M 0.49%
432,343
+54,902
+15% +$10.7M
META icon
43
Meta Platforms (Facebook)
META
$1.51T
$75.6M 0.48%
155,699
+14,694
+10% +$6.55M
IQV icon
44
IQVIA
IQV
$34.7B
$72.6M 0.46%
287,121
+43,729
+18% +$10.2M
ADBE icon
45
Adobe
ADBE
$89.5B
$70.1M 0.45%
138,929
-102,521
-42% -$58.8M
CRWD icon
46
CrowdStrike
CRWD
$187B
$69.1M 0.44%
861,584
+162,596
+23% +$12.4M
PEP icon
47
PepsiCo
PEP
$186B
$68.6M 0.44%
392,172
-65,330
-14% -$11M
NKE icon
48
Nike
NKE
$61.9B
$68.6M 0.44%
730,296
+29,841
+4% +$3.04M
SYK icon
49
Stryker
SYK
$127B
$68.4M 0.44%
190,995
+2,783
+1% +$936K
TRMB icon
50
Trimble
TRMB
$12.3B
$67.9M 0.43%
1,054,436
-49,430
-4% -$2.82M

Similar funds

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.